Jian Irish
President at METAGENOMI, INC.
Net worth: 4 M $ as of 29/04/2024
Profile
Jian Irish is currently the President, Chief Operating Officer & Director at Metagenomi, Inc. Prior to this, she held positions as the Chief Technology Officer & Director at Fosun Kite Biotechnology Co., Ltd.
from 2018 to 2020, Principal at Amgen, Inc., Vice President-Biologics Supply & Partnerships at Sanofi from 2015 to 2016, and Senior Vice President & Global Head-Manufacturing at Kite Pharma, Inc. She also briefly served as the Chief Operating Officer at Metagenomi Technologies LLC in 2021 and Affini-T Therapeutics, Inc. from 2021 to 2022.
Dr. Irish obtained her graduate and doctorate degrees from Chiba University, completed her undergraduate studies at East China University of Science & Technology, and holds an MBA from UCLA Anderson School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
METAGENOMI, INC.
1.75% | 31/03/2024 | 655,898 ( 1.75% ) | 4 M $ | 29/04/2024 |
Jian Irish active positions
| Companies | Position | Start |
|---|---|---|
| METAGENOMI, INC. | President | 31/10/2021 |
Former positions of Jian Irish
| Companies | Position | End |
|---|---|---|
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Chief Operating Officer | 31/12/2021 |
Fosun Kite Biotechnology Co., Ltd.
 Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Chief Tech/Sci/R&D Officer | 31/03/2020 |
| SANOFI | Corporate Officer/Principal | 31/12/2015 |
| AMGEN INC. | Corporate Officer/Principal | - |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | President | - |
Training of Jian Irish
| Chiba University | Doctorate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
| East China University of Science & Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| METAGENOMI, INC. | Health Technology |
| SANOFI | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 4 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
Metagenomi Technologies LLC
Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
Fosun Kite Biotechnology Co., Ltd.
Fosun Kite Biotechnology Co., Ltd. BiotechnologyHealth Technology Fosun Kite Biotechnology Co. Ltd. is a joint venture company based in China. The company's description is in Chinese, which translates to "Fosun Kite Biotechnology." The CEO of the company is Richard L. Wang. | Health Technology |
- Stock Market
- Insiders
- Jian Irish
